|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.3 USD | +0.52% |
|
+4.17% | -23.18% |
| 05-03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
| 05-03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
Fulgent Genetics, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 618.97 million compared to USD 992.58 million a year ago. Net income was USD 143.4 million compared to USD 507.36 million a year ago.
Basic earnings per share from continuing operations was USD 4.76 compared to USD 17.25 a year ago. Diluted earnings per share from continuing operations was USD 4.63 compared to USD 16.38 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -23.18% | 664M | |
| -13.90% | 8.58B | |
| +62.22% | 4.12B | |
| -3.34% | 2.48B | |
| -9.81% | 2.44B | |
| -43.01% | 2.29B | |
| -3.89% | 2B | |
| -18.68% | 1.53B | |
| -40.24% | 1.21B | |
| +9.42% | 1.12B |
FULGENT GENETICS, INC. 
